Consultation of new guidance on the conduct of clinical trials during public health emergencies in the EU
Today, the Accelerating Clinical Trials in the EU (ACT EU) initiative, jointly run by the European Commission, European Medicines Agency and Heads of Medicines Agencies of the Member States, is publishing new draft guidance on the conduct of clinical trials during public health emergencies. The document presents recommendations designed to streamline and accelerate the authorisation procedure for new clinical trials, as well as modifications to ongoing trials. It will facilitate the rapid generation of clinical evidence during public health emergencies.
Read the eNews published by DG Health and Food Safety on 5 March 2026.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (24 avril 2026). Consultation of new guidance on the conduct of clinical trials during public health emergencies in the EU. ELSIBI. Consulté le 7 octobre 2026 à l’adresse https://doi.org/10.58079/164tf
